<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01669928</url>
  </required_header>
  <id_info>
    <org_study_id>CRO1749</org_study_id>
    <nct_id>NCT01669928</nct_id>
  </id_info>
  <brief_title>Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control</brief_title>
  <acronym>HARMONY</acronym>
  <official_title>Hellenic Anglo Research Into Morning Or Evening Antihypertensive Drug deliverY Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomised crossover trial of anti-hypertensive medication dosing regimen in effective&#xD;
      blood pressure control.&#xD;
&#xD;
      To investigate whether there is a difference in 24 hour blood pressure (BP) control when&#xD;
      antihypertensive medications are taken in the morning compared with the evening.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The identification of any significant difference could lead to more effective therapeutic&#xD;
      management of arterial hypertension, which in turn would result in a reduced cardiovascular&#xD;
      burden, lower costs and a better quality of life for hypertensive patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2012</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in 24 Hour Systolic Blood Pressure</measure>
    <time_frame>6 months</time_frame>
    <description>Changes in 24 hour systolic Blood Pressure using ABPM</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Day-time ABPM Systolic BP</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Day-time ABPM Diastolic BP</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Μean Night Time ABPM Systolic BP</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Μean Night Time ABPM Diastolic BP</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Clinic - Systolic BP</measure>
    <time_frame>6 months</time_frame>
    <description>This measure was assessed at a clinic.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Clinic - Diastolic BP</measure>
    <time_frame>6 months</time_frame>
    <description>This measure was assessed at a clinic.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self Reported Side Effects</measure>
    <time_frame>12 months</time_frame>
    <description>Serious Adverse Events reported during the trial</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Score</measure>
    <time_frame>6 months</time_frame>
    <description>Quality of Life Score via questionnaire - EQ-5D-5L Score scale is 0-100, 100 optimal health state.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">103</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Evening medication</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anti hypertensive medication in the evening (between 18.00 and 23.00)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morning medication</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Antihypertensive medication in the morning(between 06.00 and 11.00)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anti-hypertensive Medication -</intervention_name>
    <description>Patients will be taking their routine blood pressure lowering medication prescribed by their GP, different patients will be using different blood pressure lowering medication.&#xD;
Dosing regimen either in the morning (between 06.00 and 11.00) or in the evening (between 18.00 and 23.00).</description>
    <arm_group_label>Evening medication</arm_group_label>
    <arm_group_label>Morning medication</arm_group_label>
    <other_name>PR1 Diruetics</other_name>
    <other_name>PR3 Beta Blockers</other_name>
    <other_name>PR4 Calcium channel blockers</other_name>
    <other_name>PR5 ACE inhibitors</other_name>
    <other_name>PR6 Angiotensin II Receptor Blockers</other_name>
    <other_name>PR7 Centrally acting agents</other_name>
    <other_name>PR8 Alpha blockers</other_name>
    <other_name>PR9 Direct Renin Inhibitors</other_name>
    <other_name>PR10 Vasodilators</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Caucasian patients aged 18-80 years;&#xD;
&#xD;
          -  History of any grade of hypertension for at least 1 year, including at least 3 months&#xD;
             of constant antihypertensive medication (consisting of ≥ 1 antihypertensive drugs,&#xD;
             each administered in one dose daily), with reasonably controlled BP (≤150/90 mmHg and&#xD;
             ≥ 115/75 mmHg on usual medication) based on previous clinic records, in the last 3&#xD;
             months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BP levels &gt; 150/90 mmHg or &lt; 115/75 mmHg in the last 3 months.&#xD;
&#xD;
          -  Postural hypotension, defined as symptoms resulting from a &gt; 20 mm Hg drop of systolic&#xD;
             BP or a &gt; 10 mm Hg drop of diastolic BP or both between 1 and 3 min after standing&#xD;
             from the sitting position.&#xD;
&#xD;
          -  Known Extreme dippers at baseline (fall of mean night time SBP &gt; 20% of mean day time&#xD;
             SBP)&#xD;
&#xD;
          -  Individuals with jobs which require night-time shift work.&#xD;
&#xD;
          -  Pregnant women or those planning to become pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil Poulter, MRCS LRCP MBBS MRCP MSc FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aristotle University of Thessaloniki</name>
      <address>
        <city>Thessaloniki</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Imperial Clinical Trials Unit</name>
      <address>
        <city>London</city>
        <zip>W2 1LA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Lemmer B. Clinical chronopharmacology: the importance of time in drug treatment. Ciba Found Symp. 1995;183:235-47; discussion 247-53. Review.</citation>
    <PMID>7656688</PMID>
  </reference>
  <reference>
    <citation>Bruguerolle B. Chronopharmacokinetics. Current status. Clin Pharmacokinet. 1998 Aug;35(2):83-94. Review.</citation>
    <PMID>9739478</PMID>
  </reference>
  <reference>
    <citation>Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010 Mar 13;375(9718):895-905. doi: 10.1016/S0140-6736(10)60308-X.</citation>
    <PMID>20226988</PMID>
  </reference>
  <reference>
    <citation>Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit. 2010 Aug;15(4):173-80. doi: 10.1097/MBP.0b013e32833c7308. Review.</citation>
    <PMID>20571367</PMID>
  </reference>
  <reference>
    <citation>Hermida RC, Ayala DE, Mojón A, Fernández JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010 Sep;27(8):1629-51. doi: 10.3109/07420528.2010.510230.</citation>
    <PMID>20854139</PMID>
  </reference>
  <reference>
    <citation>Heart Outcomes Prevention Evaluation Study Investigators, Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000 Jan 20;342(3):145-53. Erratum in: 2000 May 4;342(18):1376. N Engl J Med 2000 Mar 9;342(10):748.</citation>
    <PMID>10639539</PMID>
  </reference>
  <reference>
    <citation>Mayet J, Chapman N, Li CK, Shahi M, Poulter NR, Sever PS, Foale RA, Thom SA. Ethnic differences in the hypertensive heart and 24-hour blood pressure profile. Hypertension. 1998 May;31(5):1190-4.</citation>
    <PMID>9576134</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>July 2, 2012</study_first_submitted>
  <study_first_submitted_qc>August 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2012</study_first_posted>
  <results_first_submitted>April 29, 2019</results_first_submitted>
  <results_first_submitted_qc>March 5, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 8, 2021</results_first_posted>
  <last_update_submitted>March 5, 2021</last_update_submitted>
  <last_update_submitted_qc>March 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antihypertensive Agents</mesh_term>
    <mesh_term>Calcium Channel Blockers</mesh_term>
    <mesh_term>Angiotensin II</mesh_term>
    <mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
    <mesh_term>Angiotensin Receptor Antagonists</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Morning Medication, Then Evening</title>
          <description>Antihypertensive medication in the morning (between 06.00 and 11.00) for 6 months, then cross over to antihypertensive medication in the evening (between 18.00 and 23.00) for 6 months.&#xD;
Anti-hypertensive Medication -: Patients will be taking their routine blood pressure lowering medication prescribed by their GP, different patients will be using different blood pressure lowering medication.</description>
        </group>
        <group group_id="P2">
          <title>Evening Medication, Then Morning</title>
          <description>Anti hypertensive medication in the evening (between 18.00 and 23.00) for 6 months, then cross over to antihypertensive medication in the morning (between 06.00 and 11.00) for 6 months,&#xD;
Anti-hypertensive Medication -: Patients will be taking their routine blood pressure lowering medication prescribed by their GP, different patients will be using different blood pressure lowering medication.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="52"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Morning Medication, Then Evening</title>
          <description>Antihypertensive medication in the morning (between 06.00 and 11.00) for 6 months, then cross over to antihypertensive medication in the evening (between 18.00 and 23.00) for 6 months.&#xD;
Anti-hypertensive Medication -: Patients will be taking their routine blood pressure lowering medication prescribed by their GP, different patients will be using different blood pressure lowering medication.</description>
        </group>
        <group group_id="B2">
          <title>Evening Medication, Then Morning</title>
          <description>Anti hypertensive medication in the evening (between 18.00 and 23.00) for 6 months, then cross over to antihypertensive medication in the morning (between 06.00 and 11.00) for 6 months,&#xD;
Anti-hypertensive Medication -: Patients will be taking their routine blood pressure lowering medication prescribed by their GP, different patients will be using different blood pressure lowering medication.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="51"/>
            <count group_id="B2" value="52"/>
            <count group_id="B3" value="103"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.8" spread="11"/>
                    <measurement group_id="B2" value="62.8" spread="9.7"/>
                    <measurement group_id="B3" value="61.8" spread="10.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="103"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Greece</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Changes in 24 Hour Systolic Blood Pressure</title>
        <description>Changes in 24 hour systolic Blood Pressure using ABPM</description>
        <time_frame>6 months</time_frame>
        <population>Total of 8 withdrawals / drop outs</population>
        <group_list>
          <group group_id="O1">
            <title>Morning Medication</title>
            <description>Antihypertensive medication in the morning (between 06.00 and 11.00)</description>
          </group>
          <group group_id="O2">
            <title>Evening Medication</title>
            <description>Anti hypertensive medication in the evening (between 18.00 and 23.00)</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in 24 Hour Systolic Blood Pressure</title>
          <description>Changes in 24 hour systolic Blood Pressure using ABPM</description>
          <population>Total of 8 withdrawals / drop outs</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129.65" spread="10.66"/>
                    <measurement group_id="O2" value="129.75" spread="12.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Day-time ABPM Systolic BP</title>
        <time_frame>6 months</time_frame>
        <population>Total of 8 withdrawals / drop outs</population>
        <group_list>
          <group group_id="O1">
            <title>Morning Medication</title>
            <description>Antihypertensive medication in the morning (between 06.00 and 11.00)</description>
          </group>
          <group group_id="O2">
            <title>Evening Medication</title>
            <description>Anti hypertensive medication in the evening (between 18.00 and 23.00)</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Day-time ABPM Systolic BP</title>
          <population>Total of 8 withdrawals / drop outs</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="132.24" spread="10.86"/>
                    <measurement group_id="O2" value="132.77" spread="12.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Day-time ABPM Diastolic BP</title>
        <time_frame>6 months</time_frame>
        <population>Total of 8 withdrawals / drop outs</population>
        <group_list>
          <group group_id="O1">
            <title>Morning Medication</title>
            <description>Antihypertensive medication in the morning (between 06.00 and 11.00)</description>
          </group>
          <group group_id="O2">
            <title>Evening Medication</title>
            <description>Anti hypertensive medication in the evening (between 18.00 and 23.00)</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Day-time ABPM Diastolic BP</title>
          <population>Total of 8 withdrawals / drop outs</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.27" spread="7.73"/>
                    <measurement group_id="O2" value="80.55" spread="8.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Μean Night Time ABPM Systolic BP</title>
        <time_frame>6 months</time_frame>
        <population>Total of 8 withdrawals / drop outs</population>
        <group_list>
          <group group_id="O1">
            <title>Morning Medication</title>
            <description>Antihypertensive medication in the morning (between 06.00 and 11.00)</description>
          </group>
          <group group_id="O2">
            <title>Evening Medication</title>
            <description>Anti hypertensive medication in the evening (between 18.00 and 23.00)</description>
          </group>
        </group_list>
        <measure>
          <title>Μean Night Time ABPM Systolic BP</title>
          <population>Total of 8 withdrawals / drop outs</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122.76" spread="12.18"/>
                    <measurement group_id="O2" value="121.08" spread="14.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Μean Night Time ABPM Diastolic BP</title>
        <time_frame>6 months</time_frame>
        <population>Total of 8 withdrawals / drop outs</population>
        <group_list>
          <group group_id="O1">
            <title>Morning Medication</title>
            <description>Antihypertensive medication in the morning (between 06.00 and 11.00)</description>
          </group>
          <group group_id="O2">
            <title>Evening Medication</title>
            <description>Anti hypertensive medication in the evening (between 18.00 and 23.00)</description>
          </group>
        </group_list>
        <measure>
          <title>Μean Night Time ABPM Diastolic BP</title>
          <population>Total of 8 withdrawals / drop outs</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.92" spread="9.68"/>
                    <measurement group_id="O2" value="70.57" spread="9.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Clinic - Systolic BP</title>
        <description>This measure was assessed at a clinic.</description>
        <time_frame>6 months</time_frame>
        <population>Total of 8 withdrawals / drop outs</population>
        <group_list>
          <group group_id="O1">
            <title>Morning Medication</title>
            <description>Antihypertensive medication in the morning (between 06.00 and 11.00)</description>
          </group>
          <group group_id="O2">
            <title>Evening Medication</title>
            <description>Anti hypertensive medication in the evening (between 18.00 and 23.00)</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Clinic - Systolic BP</title>
          <description>This measure was assessed at a clinic.</description>
          <population>Total of 8 withdrawals / drop outs</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129.37" spread="11.21"/>
                    <measurement group_id="O2" value="129.81" spread="12.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Clinic - Diastolic BP</title>
        <description>This measure was assessed at a clinic.</description>
        <time_frame>6 months</time_frame>
        <population>Total of 8 withdrawals / drop outs</population>
        <group_list>
          <group group_id="O1">
            <title>Morning Medication</title>
            <description>Antihypertensive medication in the morning (between 06.00 and 11.00)</description>
          </group>
          <group group_id="O2">
            <title>Evening Medication</title>
            <description>Anti hypertensive medication in the evening (between 18.00 and 23.00)</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Clinic - Diastolic BP</title>
          <description>This measure was assessed at a clinic.</description>
          <population>Total of 8 withdrawals / drop outs</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.26" spread="7.12"/>
                    <measurement group_id="O2" value="77.41" spread="8.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Self Reported Side Effects</title>
        <description>Serious Adverse Events reported during the trial</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Morning Medication</title>
            <description>Antihypertensive medication in the morning (between 06.00 and 11.00) for 6 months&#xD;
Anti-hypertensive Medication -: Patients will be taking their routine blood pressure lowering medication prescribed by their GP, different patients will be using different blood pressure lowering medication.</description>
          </group>
          <group group_id="O2">
            <title>Evening Medication</title>
            <description>Anti hypertensive medication in the evening&#xD;
Anti-hypertensive Medication -: Patients will be taking their routine blood pressure lowering medication prescribed by their GP, different patients will be using different blood pressure lowering medication.</description>
          </group>
        </group_list>
        <measure>
          <title>Self Reported Side Effects</title>
          <description>Serious Adverse Events reported during the trial</description>
          <units>Serious Adverse Events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life Score</title>
        <description>Quality of Life Score via questionnaire - EQ-5D-5L Score scale is 0-100, 100 optimal health state.</description>
        <time_frame>6 months</time_frame>
        <population>Total of 8 withdrawals / drop outs</population>
        <group_list>
          <group group_id="O1">
            <title>Morning Medication</title>
            <description>Antihypertensive medication in the morning (between 06.00 and 11.00)</description>
          </group>
          <group group_id="O2">
            <title>Evening Medication</title>
            <description>Anti hypertensive medication in the evening (between 18.00 and 23.00)</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life Score</title>
          <description>Quality of Life Score via questionnaire - EQ-5D-5L Score scale is 0-100, 100 optimal health state.</description>
          <population>Total of 8 withdrawals / drop outs</population>
          <units>Score out of 100</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.14" spread="11.45"/>
                    <measurement group_id="O2" value="84.04" spread="10.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Morning Medication</title>
          <description>Antihypertensive medication in the morning (between 06.00 and 11.00)</description>
        </group>
        <group group_id="E2">
          <title>Evening Medication</title>
          <description>Anti hypertensive medication in the evening (between 18.00 and 23.00)</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="97"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="97"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Syncope episode</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="97"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="97"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Planned admission for ERCP with stent.</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="97"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Professor Neil Poulter</name_or_title>
      <organization>Imperial College London</organization>
      <phone>+44 20 7594 3446</phone>
      <email>n.poulter@imperial.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

